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Abstract
Background Tubulointerstitial nephritis (TIN) is an inflam-
matory disease of unknown pathogenesis. To evaluate a pos-
sible role of regulatory T cells (Tregs) in the pathophysiology
of TIN with (TINU) and without uveitis, we investigated the
presence and quantity of FOXP3+ T regulatory lymphocytes
in diagnostic kidney biopsies from pediatric patients.
Methods A total of 33 patients (14 TIN and 19 TINU) were
enrolled. The quantity of CD4+, FOXP3+ and double-positive
T cells in formalin-fixed kidney biopsies was determined
using double label immunohistochemistry with anti-human
CD4 and FOXP3 antibodies.
Results FOXP3 staining was successful in all 33 patients. In
patients with chronic uveitis, the density of FOXP3+ cells was
significantly lower (p = 0.046) than in TIN patients without
uveitis or with uveitis lasting <3 months. CD4+ staining was
successful in 23 patients. The density of all lymphocytes
(CD4+, CD4+FOXP3+ and FOXP3+ cells) was significantly
lower (p = 0.023) in patients with chronic uveitis than in other
patients.
Conclusions FOXP3+ T cells are present in kidney biopsy
samples from TIN and TINU patients. In patients with chronic
uveitis, the density of FOXP3+ T cells is significantly lower
than in other patients, suggesting a different pathomechanism
for these clinical conditions.
Keywords Tubulointerstitial nephritis . Regulatory Tcell .
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Introduction
Tubulointerstitial nephritis (TIN) is an inflammatory process
affecting primarily the renal interstitium and the tubular wall
without significant glomerular or vascular involvement [1]. In
some cases, renal symptoms are accompanied by uveal in-
flammation (TINU syndrome) [2]. TIN has been reported to
cause approximately 7% of acute kidney injuries (AKI) in the
pediatric population [3]. In the adult population, TIN accounts
approximately for 1.5─11% of all diagnostic renal biopsies
[4].
Tubulointerstitial nephritis may be caused by various virus-
es and bacterial infections and by numerous drugs [5].
However, especially in children and adolescents, the
pathomechanism of TIN remains unknown. The diagnosis of
TIN is based on histological findings in renal biopsy.
Typically, there are T-cell infiltrations, plasma cells, and eo-
sinophils in the renal interstitium and tubular walls [6].
Immunofluorescence usually remains negative, suggesting
* Sari H. Rytkönen
sari.rytkonen@fimnet.fi
1 PEDEGOResearch Unit andMedical Research Center (MRC) Oulu,
University of Oulu and Oulu University Hospital, Box 23, 90029
OYS, Oulu, Finland
2 Biomedicine Research Unit, Clinical Microbiology and
Immunology, University of Oulu, Oulu, Finland
3 Cancer and Translational Medicine Research Unit, University of
Oulu, and Department of Pathology, Oulu University Hospital, Box
50, 90029 OYS, Oulu, Finland
4 Department of Pediatrics, University of Eastern-Finland and Kuopio
University Hospital, Box 100, 70029 KYS, Kuopio, Finland
5 Department of Pediatrics, Tampere University Hospital, Box 2000,
33521 TAYS, Tampere, Finland
6 Department of Pediatric Nephrology and Transplantation, Children’s
Hospital, Helsinki University Hospital and Helsinki University,
Stenbäckinkatu 11, Box 281, 00029, Helsinki, Finland
7 Pediatric and Adolescent Medicine, Turku University Hospital, Box
51, 20520 TYKS, Turku, Finland
Pediatr Nephrol (2018) 33:287–293
DOI 10.1007/s00467-017-3796-z
that TIN is not an antibody-mediated disease. Both TIN and
TINU syndrome have been shown to be enriched in patients
with certain HLA type, potentially reflecting underlying auto-
immune mechanisms [7–9].
Naturally occurring CD4+CD25+ regulatory T cells
(nTregs) actively suppress pathological and physiological im-
mune responses. These cells contribute to the maintenance of
immunological self-tolerance and immune homeostasis by
inhibiting the activation, proliferation, and function of other
lymphocytes in physiological or pathological immune re-
sponses [10]. Tregs constantly express the x-linked transcrip-
tion factor forkhead box protein 3 (FOXP3), which is the
major regulator of the development, homeostasis, and func-
tion of regulatory T lymphocytes [11].
Regulatory T cells have been shown to be important in
many different immunological conditions such as renal allo-
graft rejection [12, 13] and inmany autoimmune diseases such
as systemic lupus erythematosus (SLE), multiple sclerosis
(MS), ankylosing spondylitis (AS) [14], and in glomerulone-
phritis (GN) [15, 16]. Mutations in the FOXP3 gene lead to
dysfunctional Treg cells causing immunodysregulation
polyendocrinopathy enteropathy X-linked syndrome (IPEX),
which accompanies severe autoimmune diseases, e.g., diabe-
tes, inflammatory bowel disease, allergy, and various forms of
renal injury [17].
The data regarding the expression of FOXP3+ T helper
cells in renal biopsy samples is restricted to a few study reports
[18, 19]. In the present study, we aimed to evaluate the pres-
ence of these cells in the kidney biopsy samples of pediatric
TIN patients. We also studied whether the expression of
FOXP3+ T cells differs between the patients with TIN and
TINU patients with or without chronic uveitis.
Materials and methods
In this nationwide study, all pediatric patients (age < 16 years
of age) diagnosed with biopsy-proven idiopathic TIN between
2001 and 2014 were enrolled. All except 6 patients had par-
ticipated in our previous studies. All TIN diagnoses were
based on kidney biopsies, which were performed before any
treatment was given. All patients had meticulous work-up to
exclude possible underlying conditions, such as respiratory
infections, sarcoidosis, connective tissue disorder, or lympho-
ma. Also, patients with suspected self-limiting, drug-induced
TIN were excluded [2, 20, 21]. A total of 42 patients from five
university hospitals in Finland were found, and stored biopsy
material was available from 33 patients. Nineteen patients
(58%) had uveitis (TINU syndrome) and 14 (42%) of them
had chronic uveitis. The median age at the time of diagnosis
was 12.7 (9.4–14.4) years (Table 1). In 10 (30%) cases immu-
nohistochemical double-staining for both CD4+ and FOXP3+
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disorientation of the sample on the slide or poor quality of the
staining. Consequently, double staining of both CD4+ and
FOXP3+ cells was successful in 23 patients.
All patients were followed up by a pediatric nephrologist
and an ophthalmologist for at least 1 year after the diagnosis of
TIN. Uveitis was classified according to standardization of
uveitis nomenclature (SUN) criteria. Chronic uveitis was de-
fined as uveitis that had lasted more than 3 months despite
treatment and/or with relapse within 3 months after
discontinuing treatment.
Laboratory samples were taken at the time of the diagnostic
kidney biopsy. Plasma creatinine (P-Crea), C-reactive protein
(CRP), blood erythrocyte sedimentation rate (ESR), and uri-
nary excretion of lowmolecular weight (LMW) proteinuria by
measuring β-2-microglobulin (β-2-MG) were analyzed from
each patient. Glomerular filtration rate (GFR) was measured
either by Cr-EDTA or by iohexol clearance. Estimated GFR
was calculated using bedside Schwartz formula.
Immunohistochemistry
Kidney biopsies were routinely formalin-fixed and embedded
in paraffin blocks after biopsy. As part of this study, paraffin
blocks were cut to 2.5-μm sections. The second phase was
antigen retrieval with Tris-EDTA (pH 9) in a microwave. The
quantities of CD4+, FOXP3+, and CD4+FOXP3+ double-
positive T cells were determined with double-label immuno-
histochemistry using anti-humanCD4 (Novacastra™ Product
Code NCL-L-CD4–368 with 1:50 dilution) and FOXP3
(Abcam, 236A/E7 with 1:100 dilution) antibodies.
Immunostainings were performed using Dako REAL™
EnVision ™ Detection System (Dako code K5007). For
CD4+ cells DAB-peroxidase substrate was used from the
same kit. For FOXP3, Vector SG substrate kit (catalog number
SK-4700 by Vector laboratories) was used (Fig. 1).
The areal density of positive cells was determined with
high magnification (×40 objective) and a graticule corre-
sponding field size of 0.063 mm2. Cells were counted in five
random fields and the mean value was calculated. The quality
of the CD4+ and FOXP3+ stainings was confirmed using a
positive control sample from tonsillar tissue. In addition to
the kidney biopsy, samples from the 33 TIN patients, 25 kid-
ney biopsy samples from Henoch–Schönlein nephritis (HSP)
patients were stained as control samples (Fig. 1).
Statistical analysis
We used IBM SPSS Statistics version 22 for statistical analy-
sis. Owing to the skewed distribution of each measured con-
tinuous variable, we used Mann–Whitney U test to compare
the results of TIN and TINU patients with or without chronic




The demographic data of the patients are presented in Table 1.
In TIN patients, ESR and P-Crea were significantly higher
(p = 0.010 and p = 0.012) and GFR was significantly lower
(p = 0.014) than in TINU patients at the time of diagnosis.
Furthermore, in patients with chronic uveitis, ESR was signif-








staining of CD4+ and FOXP3+. a
Renal biopsy from a TINU patient
with chronic uveitis, x20
magnification. b Same specimen
with ×40 magnification. c Control
tonsillar tissue, x40
magnification. d Renal biopsy
sample from a HSP patient, x40
magnification. TINU
tubulointerstitial nephritis and
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Immunohistochemistry
Immunohistochemical staining for FOXP3 was successful in
all 33 patients. The cell densities are presented in Table 2
separately for TIN patients, for patients with TINU, for pa-
tients with TINU and chronic uveitis, and for patients with
TINUwithout chronic uveitis. In patients with chronic uveitis,
the density of FOXP3+ T cells was significantly lower
(p = 0.046) than in TIN patients without uveitis or uveitis
lasting <3 months (Table 2, Fig. 2).
CD4+ staining was successful in 23 (70%) patients. The
age and gender distribution of these 23 patients did not differ
significantly from the total study population. The prevalence
of uveitis (52%, n = 12) and chronic uveitis (35%, n = 8) were
also comparable with the original population (data not
shown). The results from the double staining experiments
are shown in Table 2 and Fig. 2. The overall density of lym-
phocytes was significantly lower (p = 0.023) in patients with
chronic uveitis compared with other patients.
Immunohistochemical stainings performed on 25 kidney
biopsy samples from HSP patients were all successful. In all
25 HSP samples the density of CD4+ and FOXP3+ and double
positive cells were almost nonexistent (Fig. 1).
Discussion
A rare condition with various etiologies, TIN/TINU syndrome
is of unknown immunopathology [22]. In the present study,
we have demonstrated, to our knowledge for the first time,
that FOXP3+ T cells are present in kidney biopsy samples
from pediatric TIN patients. We also showed some evidence
for a significantly lower density of CD4+ and/or FOXP3+ T
cells in TINU patients with chronic uveitis compared with
other patients. It may well be that the immune response in
patients with chronic TINU is different from other patients,
leading to a prolonged inflammatory process.
Renal biopsies of TIN patients typically show the presence
of T lymphocytes and other mononuclear cells, and occasion-
ally eosinophils [6]. The pathomechanism in TIN is therefore
suggested to be antigen-driven molecular mimicking leading to
autoimmune-type disease [23]. A recent study by Cheng et al.
has shown evidence about an increased number of dendritic
cells in kidney biopsy samples from TIN patients and from
patients with lupus nephritis (LN) when compared with sam-
ples from minimal change disease patients [24]. In the present
study, we found CD4+FOXP3+ T cells, i.e., potential Tregs, in
the biopsy samples from TIN patients. Interestingly, in patients
with chronic uveitis indicating persistent autoimmune re-
sponse, the density of these cells was lower than in patients
with other forms of TIN. It may well be that in these patients
Treg activation is for some reason dampened, which leads to
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disease. For comparison, the density of CD4+ and FOXP3+
cells were almost non-existing in our biopsy samples from
HSP patients, which is in line with previous studies [25, 26].
No previous data regarding Tregs in TINU patients have
been published. However, it has been shown that the quantity
of FOXP3+ T cells in kidney transplants correlates positively
with long-term graft function. Patients with no chronic damage
in biopsy had a significantly higher percentage of CD3+/
FOXP3+T cells than patients with any chronic histological
damage [12, 13]. Moreover, it has been shown that the number
of FOPX3+ T cells within the entire CD4+ T cell population is
significantly higher in patients with subclinical or mild rejec-
tion than in patients with acute rejection, and it correlates neg-
atively with graft function at the time of biopsy [27], suggesting
that Tregs might reduce interstitial inflammation.
Polymorphisms in the FOXP3 gene and in genes coding vari-
ous cytokines have been shown to cause an altered inflamma-
tory response, which may result in autoimmune disease [28].
The potential role of Tregs in other autoimmune kidney
diseases has been studied in both murine and human models.
In anti-neutrophil cytoplasmic antibody (ANCA) -associated
vasculitis (AAV), the findings from human studies are con-
flicting regarding the amount of circulating Tregs, but there is
evidence that FOXP3+ Tregs are functionally impaired, with
diminished capability to suppress effector T cell (Teff) prolif-
eration [29–34]. There are several reports about the reduced
quantity and function of Treg cells in SLE patients. Xing et al.
demonstrated decreased frequency of CD4+CD25+FOXP3+
Treg cells in peripheral blood with lupus nephritis (LN) com-
pared with SLE patients without nephritis [35]. In the study by
Afeltra et al., the ratio of FOXP3+/CD3+ cells was significant-
ly lower in lupus nephritis class IV than in lupus nephritis
class V, patients with nephroangiosclerosis, and 6 patients
with acute TIN used as control patients [19].
The major limitation of the present study is the relatively
low number of patients. However, TIN is a rare disease and
this is by far one of the largest studies available in the
literature. In addition, all patients were studied and followed
up by a pediatric nephrologist and ophthalmologist using the
same protocol [21]. This meticulous work-up guarantees that
the study population represents patients with idiopathic TIN or
TINU with or without chronic uveitis. In addition, based on
our results, we are not able to draw any conclusions about the
mechanism of uveitis in this patient cohort. However, several
other autoimmune diseases that are accompanied by uveitis,
e.g., ankylosing spondylitis [36], juvenile idiopathic arthritis
[37], and SLE [38] have been shown to have impaired Treg
production or function.
Conclusions
To the best of our knowledge, this is the first report comparing
the presence of FOXP3+ T cells in biopsy samples from pa-
tients with TINU and patients with TINU and chronic uveitis.
FOXP3+ T cells could be found in all patients; however, in
patients with chronic uveitis the density of Tregs was signifi-
cantly lower than in other patients. This may indicate a differ-
ent pathomechanism behind these clinical conditions, imply-
ing that in TINU patients with chronic uveitis, the
pathomechanism may be of autoimmune origin. Because of
the relatively low number of patients, replication studies with
larger patient cohorts are needed.
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Fig. 2 Comparison of FOXP3+ and/or CD4+ cell density between TIN,
tubulointerstitial nephritis and uveitis syndrome (TINU) and patients with
or without chronic uveitis. aDifference in all FOXP3+ cells between TIN
and TINU patients, n = 33. b Difference in all FOXP3+ cells between
patients with and without chronic uveitis, n = 33. cDifference between all
cells (CD4+FOXP3+, CD4+, and FOXP3+ cells) between patients with
and without chronic uveitis, n = 23. TIN tubulointerstitial nephritis, TINU
tubulointerstitial nephritis and uveitis syndrome. Chronic uveitis was
defined as uveitis that had lasted more than 3 months despite treatment
and/or with relapse within 3 months after discontinuing treatment. Each
boxplot presents the median and the 25th and 75th centiles; error bars
represent the smallest and the largest values
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